Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04039789
Other study ID # CCI 11/18
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 17, 2021
Est. completion date December 31, 2023

Study information

Verified date March 2024
Source Gerencia de Atención Primaria, Madrid
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Objectives: To evaluate the effectiveness of a structured educational intervention in physical exercise "Active Legs" as an adjuvant treatment to improve the healing of chronic venous ulcers at 3 months of follow-up, compared with the usual practice in people treated in primary care. Secondary objectives: To evaluate if the intervention active legs as an adjuvant treatment produces better results than usual practice in: degree of healing, recurrence, complete healing at 6 months, pain and quality of life. Describe degree of adherence and satisfaction with the intervention. Design: Randomized, multicenter, pragmatic, open clinical trial of parallel groups with 6 months of follow-up. Setting: Primary Care Health Centers (Madrid). Subjects: Patients with venous ulcers, with treatment in the nursing consultation of the participating centers. Sample: 224 participants (112 in each group). Intervention: Both groups will receive the usual treatment of cleaning, debridement based on humid environment cure and multilayer compression therapy according to the recommendations of Community of Madrid. The intervention group will also receive the structured educational intervention of lower limbs physical exercise and daily walking patterns. Variables: Main: complete healing at 3 months follow-up. Secondary: Degree of healing; ulcer area; quality of life; pain, related to the healing process, prognosis and recurrences; Sociodemographic and related adherence and satisfaction. Data analysis: Main effectiveness: comparison of the incidence of ulcers with complete healing at 3 months of follow-up in both groups, time to complete healing (Kaplan-Meier and Log-rank test). Adjustment of prognostic factors (Cox regression).


Recruitment information / eligibility

Status Completed
Enrollment 44
Est. completion date December 31, 2023
Est. primary completion date December 10, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Individuals with a diagnosis of venous ulcers registered in electronic clinical history (history of chronic venous insufficiency and/or venous ulcer) and presence of an ankle brachial index (ABI) greater than 0.8 and less than 1.3. - Presence at least a venous ulcer of 1cm or more in diameter. If the participant has more than one lesion, the nurse will select the lesion with the highest Resvech 2.0 score for the study. - Independent ambulation or with the help of devices. - Individuals who able to follow the demands of the trial and who provide their written informed consent to participate. Exclusion Criteria: - Patients with mixed ulcers. - Acute phase deep vein thrombosis. - Patients on treatment with antineoplastic agents. - Decompensated heart failure. - Rheumatoid arthritis. - Acute phase dermatitis, at the time of the study. - Patients immobilized at home, institutionalized or displaced residing outside the area where the research is conducted for more than 6 months a year or during the performance of the intervention. - Absolute contraindication to perform physical exercise. - Patients who are simultaneously participating in another clinical trial.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Project active legs
Home program of exercises of lower extremities includes the performance of 4 exercises of lower extremities of progressive difficulty that must be carried out at home 5 days a week, twice a day and walking progressively until reaching the marked goal (150 min / week (30 minutes for 5 days a week)).
Procedure:
Usual care
Evaluation, cleaning, debridement, topical treatment (moist healing) and compressive therapy according to the recommendations for the treatment of chronic cutaneous ulcers of the Community of Madrid.

Locations

Country Name City State
Spain Borja Jesús Herraiz Ahijado Madrid

Sponsors (1)

Lead Sponsor Collaborator
Gerencia de Atención Primaria, Madrid

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Complete healing at 6 months of follow-up (yes/no) (complete and sustained epithelialisation for at least 2 weeks). 6 months
Primary Time elapsed between start of the study and complete healing of the wound (in days) 6 months
Secondary Degree of healing (Resvech 2.0) The questionnaire consists of 6 dimensions with ascending scoring scales according to the severity of the dimension studied. It is divided into: depth (0 to 4), size (0 to 6), borders (0 to 4), wound bed (0 to 4), exudate (0 to 3) and signs and symptoms of infection (0 to 14). The total score ranges from 0 to 35. Measured at the beginning (basal) and fortnightly up to 3 months and at 6 months.
Secondary Ulceral area In cm2. Measured by digital photography. Measurement through digital photography and subsequent treatment of the image using the open source Java image processing program "The ImageJ ecosystem" and its subsequent calculation using the Visitrack device. Measured at the beginning (basal) and fortnightly up to 3 months and at 6 months.
Secondary Health-related quality of life for patients with venous ulcers (CCVUQ-e) It is a questionnaire that measures quality of life in patients with venous ulcers. In addition to a global synthetic quality of life score, it has 4 dimensions: Social interaction, Cosmesis (body image), Emotional state and Domestic activities. Both the general score and the dimensions have a score that ranges from 0 to 100, where 0 is the best quality of life and 100 the worst quality of life. Measured at the beginning (baseline), in the middle (3 months) and at the end of the study (6 months).
Secondary Perceived pain: visual analogical scale of the McGill questionnaire The visual analogical scale of the McGill questionnaire will be used. A greater than 20mm in the Visual Analog Scale of pain scale will be considered a clinically significant change.
It goes from "no pain" 0 to "unbearable pain" 10, the patient will mark that point on the line that best reflects the pain he suffers.
Measured at the beginning (baseline), in the middle (3 months) and at the end of the study (6 months).
Secondary Level of adherence to the intervention "Active Legs". Number of steps. Daily record using the Yamax PZ270 pedometer (15 days memory) In the intervention group. Measured biweekly coinciding with follow-up visits up to 3 months and 6 months.
Secondary Level of adherence to the intervention "Active Legs". Time. The time in minutes / day In the intervention group. Measured biweekly coinciding with follow-up visits up to 3 months and 6 months.
Secondary Level of adherence to the intervention "Active Legs". The self-reported information by the patient of the domiciliary exercise program. By registering in the activity diary, classifying it as "Excellent" in 75% or more of the prescribed sessions, "Good" between 50-74%, "Moderate" between 25-49% and "Poor" less than 25%. In the intervention group. Measured biweekly coinciding with follow-up visits up to 3 months and 6 months.
Secondary Age (sociodemographic variables) in years Measured at the beginning (baseline)
Secondary Sex (sociodemographic variables) Male/Female Measured at the beginning (baseline)
Secondary Living alone (sociodemographic variables) Yes/no Measured at the beginning (baseline)
Secondary Employment status (sociodemographic variables) housewife / unemployed / student / worker employee account / worker own account Measured at the beginning (baseline)
Secondary Education level (sociodemographic variables) low / medium / high Measured at the beginning (baseline)
Secondary Weight (variables related to the healing process) in kilograms. weight and height will be combined to report BMI in kg/m^2 Measured at the beginning (baseline)
Secondary Height (variables related to the healing process) in meters. weight and height will be combined to report BMI in kg/m^2 Measured at the beginning (baseline)
Secondary Underlying disease (variables related to the healing process) (yes / no) for heart failure, renal failure, hypertension, diabetes mellitus, rheumatoid arthritis, asthma, chronic obstructive pulmonary disease, osteoarthritis, deep vein thrombosis, peripheral arterial vasculopathy, varicose veins. Measured at the beginning (baseline)
Secondary ABI (variables related to the healing process) The Ankle Brachial Index (ABI) is the systolic pressure at the ankle, divided by the systolic pressure at the arm. It has been shown to be a specific and sensitive metric for the diagnosis of Peripheral Arterial Disease (PAD). Measured at the beginning (baseline)
Secondary Tobacco consumption (variables related to the healing process) no smoker / smoker / ex-smoker Measured at the beginning (baseline)
Secondary Alcohol consumption (variables related to the healing process) volume grams of alcohol / week Measured at the beginning (baseline)
Secondary Topical and systemic treatment (variables related to the healing process) (yes/no) for hydrocellular dressings, alginates, hydrogels, collagenase, silver dressings, low adhesion dressings, silver sulfadiazine in ointment, other antibiotics in ointment, moisturizing products for the skin. Measured at the beginning (baseline)
Secondary Adherence to multilayer compression therapy (variables related to the healing process) (yes/no) Measured at the beginning (basal) and fortnightly until 3 months and at 6 months .
Secondary Physical activity level measured by the Minnesota free time physical activity questionnaire (variables related to the healing process) It allows to measure the energy expenditure during free time and allows to classify individuals in activity categories. In metabolic energy turnover (METS)-min/14 days. Interpreting as: very active above 5000 METS-min / 14 days, Active between 3000 and 4999 METS-min / 14 days, Moderately active between 1250 and 2999 METS-min / 14 days and sedentary less than 1250 METS-min / 14 days . Measured at the beginning (baseline), in the middle (3 months) and at the end of the study (6 months).
Secondary Type of daily walking (variables related to the healing process) Independent / Independent with technical assistance (cane, crutches or walker with or without wheels) / With the help of the participation of a person without technical assistance / With the help of the participation of a person with technical help Measured at the beginning (baseline)
Secondary Location of the ulcer (prognostic variables) internal lateral aspect/ supra-malleolar area/ anterior area of the leg/ external lateral aspect of the leg/ posterior aspect of the leg Measured at the beginning (baseline)
Secondary Number of ulcers at the time of the study (prognostic variables) in number Measured at the beginning (baseline)
Secondary Time in days of evolution of the venous ulcers before inclusion in the study (prognostic variables) in days Measured at the beginning (baseline)
Secondary Recurrent ulcer (prognostic variables) (yes/no) Measured at the beginning (baseline)
Secondary Recurrence (variables related to recurrences) (yes / no) measured at 6 months of follow-up
Secondary Use of compression stockings (variables related to recurrences) (Yes/no) for Light / normal / strong compression measured at 6 months of follow-up
Secondary Hydration of the legs (variables related to recurrences) (Yes/no) measured at 6 months of follow-up
See also
  Status Clinical Trial Phase
Withdrawn NCT02561013 - A Clinical Study to Assess a Compression Device in Patients With Venous Leg Ulcers N/A
Recruiting NCT05364112 - Utilization of Compreflex Wraps in Patients With Chronic Venous Insuffciency N/A
Completed NCT00656383 - Effectiveness and Efficiency of Two Models of Delivering Care to a Chronic Wound Population N/A
Active, not recruiting NCT02973893 - Study of VF001-DP in Patients With Chronic Venous Leg Ulcers Phase 2
Not yet recruiting NCT02873728 - Remote Ischemic Conditioning for Treatment of Chronic Wounds N/A
Completed NCT01998932 - Predictive of Biomarkers of Healing in Chronic Venous Ulceration of the Lower Limb N/A
Recruiting NCT06135246 - Laser Therapy for Venous Leg Ulcers N/A
Active, not recruiting NCT03744858 - The Role of Pyroptosis in Chronic Venous Disease
Completed NCT01449422 - Clinical Trial to Evaluate the Efficacy, Tolerance and Acceptability of URGO Dressing vs a Hydrofibre in the Local Management of Venous or Predominantly Venous Mixed Leg Ulcers. Phase 4
Completed NCT00838500 - THERMES ET VEINES: Spa for Prevention of Leg Ulcers Phase 3
Completed NCT04280679 - Treatment of Insufficient Superficial and Perforatring Veins of the Lower Limb Using HIFU N/A
Completed NCT02512159 - Skin Ulcers Treatment With an Handicraft Topical Device Phase 4
Completed NCT02896725 - Wool-derived Keratin Dressings for Venous Leg Ulcers N/A
Completed NCT04310280 - Effects of Local Insulin on Varicose Ulcers for Wound Healing Phase 3
Completed NCT02626156 - Cooling Leg and Foot Ulcer Skin Post Healing to Prevent Ulcer Recurrence Phase 2
Recruiting NCT03127904 - Vein Fitness System vs Compressive Therapy for Venous Ulcers: a Bayesian Adaptive Trial N/A
Terminated NCT00727701 - Study of Individualized Wound Prevention Instruction to Prevent Venous Ulcer Development Phase 1
Withdrawn NCT00648674 - A Post-Marketing Clinical Study of Apligraf for Venous Leg Ulcers Phase 4
Completed NCT00399308 - Evaluation of Safety and Activity of Celaderm in Healing Venous Leg Ulcers Phase 1/Phase 2
Completed NCT00426972 - Trial of Zesteem (Estradiol) in Healing of Split Thickness Skin Graft Donor Sites Phase 3